Davis Polk advised Commonwealth Bank of Australia on the deal. Commonwealth Bank of Australia (“CBA”) entered into an arrangement with Gemini Trust Company, LLC (“Gemini”) to allow CBA...
Commonwealth Bank of Australia’s Crypto Partnership With Gemini Trust Company
Privia Health’s $174 Million Shares Secondary Offering
Davis Polk advised Privia Health Group on the offering. Privia Health Group, Inc. announced its secondary offering of 6,000,000 shares of common stock by certain selling...
Affimed’s $100 Million Common Shares Offering
Davis Polk advised the sales agent, Jefferies, in the transaction. Affimed N.V. established its at-the-market offering program of up to $100 million gross sales price of its common...
Reliance New Energy Solar’s Acquisition of REC Solar
Baker McKenzie advised China National Bluestar (Group) Co Ltd. and REC Solar Holdings AS on the transaction. Davis Polk advised Reliance New Energy Solar on the...
Qualcomm and SSW Partners’ Acquisition of Veoneer
Paul, Weiss, Rifkind, Wharton & Garrison advised Qualcomm. Davis Polk & Wardwell advised SSW Partners. Skadden, Arps, Slate, Meagher & Flom and Roschier advised Veoneer on...
Comcast’s Partnership with ViacomCBS
Davis Polk advised Comcast on the deal. Hogan Lovells and Shearman & Sterling advised ViacomCBS. Comcast signed its partnership with ViacomCBS to launch a new subscription...
SOPHiA GENETICS’ $234 Million Initial Public Offering on Nasdaq
Homburger and Davis Polk advised SOPHiA GENETICS on the deal. Lenz & Staehelin acted as Swiss counsel to the underwriters. SOPHiA GENETICS SA listed its shares...
Novo Nordisk’s Acquisition of Neotope Neuroscience
Davis Polk, working alongside Matheson, advised Novo Nordisk on the deal. Novo Nordisk A/S completed its acquisition of Neotope Neuroscience Limited from Prothena Biosciences Limited for...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
UiPath’s $1.54 Billion Initial Public Offering
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
Doma’s $3 Billion Business Combination With Capitol Investment Corp. V
Davis Polk advised Doma Holdings, Inc., while Latham & Watkins LLP represented Capitol Acquisition Corp. V on the deal.Doma Holdings, Inc. (f/k/a States Title Holding, Inc.)...
Shiseido Company’s Joint Venture With CVC Asia Pacific Limited
Davis Polk advised Shiseido Company on the deal. Clifford Chance, White & Case, Skrine, and Nagashima Ohno & Tsunematsu acted for CVC. Baker & McKenzie advised...